26/10/2026 EMVision Medical Devices Ltd ACN 620 388 230 Suite 4.01, 65 Epping Rd Sydney NSW 2113 02 8667 5337 contact@emvision.com.au APPENDIX 4C – 30 SEPTEMBER 2026 QUARTERLY ACTIVITIES & CASHFLOW REPORT Highlights • By early October, the Pivotal (Validation) trial surpassed 230 patients...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- $4.3m Non-Dilutive R&D Tax Rebate Received
- First Responder Successfully Trialled with MSU
- emu Regional Benefits Study Advancing
- emu Pivotal Trial Recruitment Surpasses 200 Patients
- Appendix 4E & Annual Report to 30 June 2026
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices